Niagen Bioscience Inc$10.14 %
Analyst Rating: Hold
Stock Details
CEO
Robert N. Fried
Sector
Healthcare
Industry
Biotechnology
Full Time Employees
104
Address
10900 Wilshire Blvd, Suite 600, Los Angeles, CA, 90024
Niagen Bioscience Inc is a bioscience company dedicated to healthy aging. The Company leads research on nicotinamide adenine dinucleotide.
Top Competitors
Income Statement
Financials
Selected Year
Revenue Estimates
EPS Estimates
Net Income Estimates
Price target for Niagen Bioscience Inc $10.14
$0
Min Forecast(+0% )
$249.61
Avg Forecast( +0% )
$325
Max Forecast(+0%)
EPS
Revenue
Institutional Holder
Loading institutional holder data...
Congress Tracker
Showing 0 of 0 results
Insider Trading of Key Employees
Showing 0 of 0 results